2023/10/09 by Catharina C. Moor, Ogugua Ndili Obi, Ogugua Ndili +4
Medicine · #Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis #Rheumatoid Arthritis Research and Therapies #Sarcoidosis and Beryllium Toxicity Research
paper · doi:10.1016/j.jaut.2023.103123
openalex publication_date 2023/10/09 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30
Having sarcoidosis often has a major impact on quality of life of patients and their families. Improving quality of life is prioritized as most important treatment aim by many patients with sarcoidosis, but current evidence and treatment options are limited. In this narrative review, we describe the impact of sarcoidosis on various aspects of daily life, evaluate determinants of health-related quality of life (HRQoL), and provide an overview of the different patient-reported outcome measures to assess HRQoL in sarcoidosis. Moreover, we review the current evidence for pharmacological and non-pharmacological interventions to improve quality of life for people with sarcoidosis.